Risk factors for poorer quality of life in patients with neovascular age-related macular degeneration: a longitudinal clinic-based study
- PMID: 36697902
- PMCID: PMC10482823
- DOI: 10.1038/s41433-023-02407-0
Risk factors for poorer quality of life in patients with neovascular age-related macular degeneration: a longitudinal clinic-based study
Abstract
Background/objectives: To examine the risk factors for poor vision-related and health-related quality of life (QoL) in patients with neovascular age-related macular degeneration (nAMD) who present for anti-vascular endothelial growth factor (anti-VEGF) therapy.
Methods: In a clinic-based cohort of 547 nAMD patients who presented for treatment, the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ25), Short-Form 36 (SF-36) and EuroQoL EQ-5D-5L questionnaires were administered to assess vision-related and health-related QoL. Of these, 83 participants were followed up one-year later to provide longitudinal data.
Results: Individuals with mild or moderate visual impairment or blindness at baseline had significantly lower NEI-VFQ-25 scores at follow-up. The presence of ≥3 chronic diseases was associated with lower SF-36 mental component scores (MCS) (p = 0.04) and EQ-VAS scores (p = 0.05). Depressive symptoms were associated with significantly lower MCS (p < 0.0001) and EQ-VAS scores (p = 0.02). Individuals with versus without impaired basic activities of daily living (ADLs) exhibited NEI-VFQ-25 and EQ-VAS scores that were 10.96 (p = 0.03) and 0.13 (p = 0.02) points lower. Those with impaired instrumental ADLs scored 11.62 (p = 0.02), 13.13 (p < 0.0001) and 15.8 (p = 0.0012) points lower in the NEI-VFQ-25, SF-36 physical component score and EQ-5D-5L summary score, respectively.
Conclusions: The QoL of nAMD patients is affected by visual acuity as well as patients' medical history, mental health and functional status.
© 2023. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.
Conflict of interest statement
The authors declare no competing interests.
Comment on
-
Risk Factors for Poor Quality of Life among Patients with Age-Related Macular Degeneration.Semin Ophthalmol. 2017;32(6):772-780. doi: 10.1080/08820538.2016.1181192. Epub 2016 Aug 10. Semin Ophthalmol. 2017. PMID: 27648680
References
-
- Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta- analysis. Lancet. 2014;2:106–16. - PubMed
-
- Department of Health. PBS Expenditure and Prescriptions Report 1 July 2019 to 30 June 2020. (PBS Information Management Section, Canberra, ACT, 2020.
-
- Inan S, Cetinkaya E, Duman R, Dogan I, Inan UU. Quality of life among patients with age-related severe macular degeneration assessed using the NEI-VFQ, HADS-A, HADS-D and SF-36 tests. A cross-sectional study. Sao Paulo Med J. 2019;137:25–32. doi: 10.1590/1516-3180.2018.0195071218. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
